You have 9 free searches left this month | for more free features.

α-Galactosidase

Showing 1 - 25 of 1,154

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Screening for Fabry Disease in Renal Transplantation

Unknown status
  • Fabry Disease
  • Nephropathy
  • Screening for Fabry disease
  • Screen for α-galactosidase mutation
  • Montpellier, France
    Uh Montpellier
Jan 6, 2020

Fabry Disease Under Enzyme Replacement Therapy With

Recruiting
  • Fabry Disease
  • Berlin, Germany
  • +7 more
Oct 17, 2023

Pain, Neuropathic Trial (Cannabis sativa L., folium cum flore, Placebo)

Not yet recruiting
  • Pain, Neuropathic
  • Cannabis sativa L., folium cum flore
  • Placebo
  • (no location specified)
May 17, 2022

Fabry Disease, Alpha Galactosidase A Deficiency Trial in Austria, United Kingdom, United States (agalsidase beta)

Recruiting
  • Fabry Disease
  • Alpha Galactosidase A Deficiency
  • agalsidase beta
  • Decatur, Georgia
  • +4 more
May 4, 2022

Heart Involvement in Fabry Disease With T1 Mapping

Completed
  • Fabry Disease
  • T1 mapping
  • Manchester, United Kingdom
    Manchester Univiersty Foundation Trust
Oct 19, 2021

Fabry Disease Trial in United Kingdom, United States (ST-920)

Recruiting
  • Fabry Disease
  • ST-920
  • Irvine, California
  • +20 more
Feb 1, 2023

IBS - Irritable Bowel Syndrome Trial in Helsinki (Control cracker, Enzyme-treated cracker)

Active, not recruiting
  • IBS - Irritable Bowel Syndrome
  • Control cracker
  • Enzyme-treated cracker
  • Helsinki, Uusimaa, Finland
    University of Helsinki
May 17, 2022

Fabry Disease, Fabry Disease, Cardiac Variant, Lysosomal Storage Diseases Trial in Wuerzburg (blood sampling

Enrolling by invitation
  • Fabry Disease
  • +4 more
  • blood sampling (alpha-Galactosidase & LysoGb3)
  • Wuerzburg, Bavaria, Germany
    University Hospital Wuerzburg
Jul 2, 2021

Fabry Disease Trial in Bron, Lyon (T1 mapping measurement)

Not yet recruiting
  • Fabry Disease
  • T1 mapping measurement
  • Bron, France
  • +1 more
Jun 27, 2023

Fabry Disease Trial in United Kingdom, United States (Migalastat HCl 150 mg)

Completed
  • Fabry Disease
  • Migalastat HCl 150 mg
  • Tampa, Florida
  • +7 more
Nov 1, 2021

Fabry Disease Trial in United States (agalsidase alfa)

No longer available
  • Fabry Disease
  • agalsidase alfa
  • Tucson, Arizona
  • +24 more
May 19, 2021

18F-0502B PET Imaging Targeting a-synuclein in Diagnosis of

Recruiting
  • Positron-Emission Tomography
  • Alpha Synuclein Pathology
    • Shanghai, China
      Huashan Hospital
    Mar 13, 2023

    a-thalassemia Trial in Nanning (a-globin restored autologous hematopoietic stem cells)

    Recruiting
    • α-thalassemia
    • α-globin restored autologous hematopoietic stem cells
    • Nanning, Guangxi, China
      PLA Joint Logistic Support Force No. 923 Hospital
    May 6, 2023

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Early Diagnosis of Hepatocellular Carcinoma (HCC)

    Recruiting
    • HCC
    • +4 more
    • Biomarker dosage
    • Castellana Grotte, Bari, Italy
      RCCS "Saverio de Bellis"
    Mar 23, 2023

    Cardiac Functions in Type 1 Diabetes Mellitus

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • transthoracic echocardiography
    • (no location specified)
    Nov 12, 2023

    Myeloid Leukemia, MDS Trial (IFN-?)

    Not yet recruiting
    • Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Nov 15, 2023

    Recurrent Aphthous Stomatitis Trial (a-Mangostin Hydrogel Film With Chitosan Alginate Base, Placebo)

    Not yet recruiting
    • Recurrent Aphthous Stomatitis
    • α-Mangostin Hydrogel Film With Chitosan Alginate Base
    • Placebo
    • (no location specified)
    Sep 14, 2023

    Non-segmental Vitiligo Trial (skin biopsy)

    Not yet recruiting
    • Non-segmental Vitiligo
    • skin biopsy
    • (no location specified)
    Aug 6, 2023

    Ureteric Stone of Lower Third of Ureter Trial (Tamsulosin Oral Capsule)

    Not yet recruiting
    • Ureteric Stone of Lower Third of Ureter
    • Tamsulosin Oral Capsule
    • (no location specified)
    Aug 3, 2023

    Recurrent Unexplained Implantation Failure Trial (Certolizumab (CIMZIA® ; TNF-a antagonist), Placebo (NaCl 0.9 % solution))

    Not yet recruiting
    • Recurrent Unexplained Implantation Failure
    • Certolizumab (CIMZIA® ; TNF-α antagonist)
    • Placebo (NaCl 0.9 % solution)
    • (no location specified)
    Jun 30, 2023

    Transfusion-dependent a-Thalassemia Trial (GMCN-508A Drug Product)

    Not yet recruiting
    • Transfusion-dependent α-Thalassemia
    • GMCN-508A Drug Product
    • (no location specified)
    Feb 24, 2023

    Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)

    Not yet recruiting
    • Inflammatory Response
    • Cardiac Disease
    • Colchicine 0.5 MG
    • Placebo
    • (no location specified)
    Nov 1, 2023

    GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

    Completed
    • Periodontitis
    • Periodontal clinical measurements and GCF sampling
    • Aydın, Turkey
      Adnan Menderes University, Faculty of Dentistry, Department of P
    Dec 8, 2022

    Quality of Life in Thalassemic Patients at Assiut University

    Not yet recruiting
    • Thalassemia
    • Abdominal ultrasound
    • (no location specified)
    Mar 17, 2023